EUVIMEDEUVIMED entdecken
Crossref

Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and Biomarkers

Rachna Malani, Ankush Bhatia, Allison Betof Warner, Jonathan T Yang

Seminars in Neurology · 01.12.2023 · 43 (06) · 859-866

DOI: 10.1055/s-0043-1776996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Seminars in Neurology, erschienen am 01.12.2023. Verfasst von Rachna Malani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. Hauptthemen laut MEDLINE: Meningeal Carcinomatosis, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leptomeningeal metastases/diseases (LMDs) are a late-stage complication of solid tumor or hematologic malignancies. LMD is spread of cancer cells to the layers of the leptomeninges (pia and arachnoid maters) and subarachnoid space seen in 3 to 5% of cancer patients. It is a disseminated disease which carries with it significant neurologic morbidity and mortality. Our understanding of disease pathophysiology is currently lacking; however, advances are being made. As our knowledge of disease pathogenesis has improved, treatment strategies have evolved. Mainstays of treatment such as radiotherapy have changed from involved-field radiotherapy strategies to proton craniospinal irradiation which has demonstrated promising results in recent clinical trials. Systemic treatment strategies have also improved from more traditional chemotherapeutics with limited central nervous system (CNS) penetration to more targeted therapies with better CNS tumor response. Many challenges remain from earlier clinical detection of disease through improvement of active treatment options, but we are getting closer to meaningful treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningeal CarcinomatosisNeoplasmsHumansMeningesBiomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Department of Neurology, Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin.
  • Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California.
  • Department of Radiation Oncology, Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington.

Zitieren

APA

Malani, R., Bhatia, A., Warner, A. B., & Yang, J. T. (2023). Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and Biomarkers. Seminars in Neurology, 43(06), 859-866. https://doi.org/10.1055/s-0043-1776996

Vancouver

Malani R, Bhatia A, Warner AB, Yang JT. Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and Biomarkers. Seminars in Neurology. 2023;43(06):859-866. doi:10.1055/s-0043-1776996

BibTeX
@article{Malani2023,
  author = {Malani, Rachna and Bhatia, Ankush and Warner, Allison Betof and Yang, Jonathan T},
  title = {Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and Biomarkers},
  journal = {Seminars in Neurology},
  year = {2023},
  volume = {43},
  number = {06},
  pages = {859--866},
  doi = {10.1055/s-0043-1776996}
}
Kostenlos starten →